Singlera Genomics
A developer of 'liquid biopsy' analysis reagents and software, focusing on determing methylation haplotypes across many thousands of genomic locations in cell-free DNA.
Launch date
Employees
Market cap
-
Enterprise valuation
€50—75m (Dealroom.co estimates Jul 2024.)
San Diego California (HQ), Shanghai Shanghai (founding location)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$20.0m | Series A | ||
$60.0m | Series A | ||
$153m | Series B | ||
N/A | Late VC | ||
* | $45.0m Valuation: $764m | Series B | |
* | CNY100m | Late VC | |
Total Funding | €265m |
Recent News about Singlera Genomics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.